MAPT and Alzheimer disease: Disturbances in iron metabolism have been coupled to several neurodegenerative diseases [70] and, indeed, iron, either directly bound to amyloid and tau lesions [71] or associated to cytoplasmic RNA [72], is known to play a toxic role in AD pathology [62], and cause oxidative damage and neurodegeneration.